Skip to main content

Table 2 Transfusion characteristics

From: There is no dose–response relationship between allogeneic blood transfusion and healthcare-associated infection: a retrospective cohort study

Patients

Overall

Non-HAI

HAI

P

RBCs

    

 No

6868

6531

337

 

 Amount of transfusion [median (IQR)]

2 (2–4)

2 (2–3)

2 (2–4)

< 0.001

 Frequency of transfusion [median (IQR)]

1 (1–2)

1 (1–2)

1 (1–3)

0.013

Cryoprecitation

    

 No

59

56

3

 

 Amount of transfusion [median (IQR)]

1 (1–1)

1 (1–1)

1 (1–1)

0.521

 Frequency of transfusion [median (IQR)]

1 (1–1)

1 (1–1)

1 (1–1)

0.547

FFPs

    

 No

1264

1189

75

 

 Amount of transfusion [median (IQR)]

350 (200–600)

350 (200–600)

400 (200–750)

0.315

 Frequency of transfusion [median (IQR)]

1 (1–3)

1 (1–3)

1 (1–3)

0.952

Platelets

    

 No

762

697

65

 

 Amount of transfusion [median (IQR)]

1 (1–2)

1 (1–2)

1 (1–3)

0.010

 Frequency of transfusion [median (IQR)]

1 (1–2)

1 (1–2)

1 (1–2)

0.060

Time between (first) transfusion and HAI (days)

 RBCs

  

9 (6–15)

 

 Cryoprecitation

  

8 (4–14)

 

 FFPs

  

10 (6–16)

 

 Platelets

  

8 (4–13)